| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 0 | ||||
| Sells | 10 | -121K | 100% | $61.25 | -$7.44M |
| Net | -10 | -121K | -100% | -$7.44M |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Kevin T. Conroy | President and CEO, Director | $75.8M | -$2.82M | -3.59% | Apr 30, 2024 |
| Sarah Condella | EVP, Human Resources | $5.38M | -$1.03M | -16.1% | Apr 30, 2024 |
| Katherine S. Zanotti | Director | $4.21M | Jun 13, 2024 | ||
| Everett Cunningham | Chief Commercial Officer | $3.81M | -$1.3M | -25.5% | Apr 30, 2024 |
| James Edward Doyle | Director | $3.34M | -$115K | -3.33% | Jun 13, 2024 |
| D. Scott Coward | Director | $3.3M | -$172K | -4.95% | Jun 13, 2024 |
| Jacob A. Orville | EVP, GM, Screening | $2.22M | -$427K | -16.1% | Aug 5, 2024 |
| Brian Baranick | EVP, GM, Precision Oncology | $2.03M | -$518K | -20.3% | Aug 5, 2024 |
| Kathleen Sebelius | Director | $1.92M | Jun 13, 2024 | ||
| Jeffrey Thomas Elliott | Chief Financial Officer | $1.75M | -$594K | -25.4% | Apr 30, 2024 |
| Pierre Jacquet | Director | $1.73M | Jun 8, 2023 | ||
| Daniel J. Levangie | Director | $1.71M | -$288K | -14.4% | Jun 13, 2024 |
| Freda C. Lewis-Hall | Director | $1.45M | Jun 8, 2023 | ||
| Shacey Petrovic | Director | $1.38M | Jun 13, 2024 | ||
| Paul J. Clancy | Director | $1.21M | Jun 13, 2024 | ||
| James Herriott | SVP, General Counsel & Sec | $1M | -$166K | -14.2% | Apr 30, 2024 |
| Timothy J. Scannell | Director | $419K | Oct 31, 2023 | ||
| Thomas D. Carey | Director | $389K | Jun 2, 2021 | ||
| Michael Barber | Director | $327K | Jun 13, 2024 | ||
| Aaron Bloomer | EVP, Chief Financial Officer | May 15, 2024 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|